Chile’s Communist and Izquierda Ciudadana parties have met with the mayor of Recoleta, Daniel Jadue, in order to learn more about the operations of the “Ricardo Silva Soto Popular Pharmacy”, which opened on October 15 and will soon start selling low-cost drugs and medicines to the small town’s inhabitants.
The novel initiative was backed by the left-leaning coalition, whose members commented on the underlying issues, which they considered to be crucial to the community, such as the high price of medicines. The experiment undertaken by the Recoleta community is a direct response to the scandal, revealed early this year, involving a price-fixing cartel comprising the three largest drugstore chains in the country.
“This initiative is not only worthy of being replicated in the country’s other municipalities, it is also capable of solving a real and concrete problem. There are 54 communities in Chile that have no drugstores at all, which makes this a very complex situation, with people unable to access medication at all.” said representative Karol Cariola, a member of the lower chamber’s Health Commission.
The municipal drugstore project has been heavily criticised by some in the private sector, describing it as anti-competitive and possibly unconstitutional. Carlos Vallejo , Regional President of the Independent Pharmacy and Pharmaco-Chemists’s Association, has specifically called the possible spread of these pharmacies as a threat to the survival of independent drugstores unable to compete with the low prices and lower regulatory burden than that likely to be faced by these government-backed rivals.
Source: El Mostrador; El Sur
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Synopsys Secures EU Approval for $35 Billion Ansys Acquisition
Jan 13, 2025 by
CPI
New UK Legislation to Combat Ticket Resale and Algorithmic Price-Fixing
Jan 12, 2025 by
CPI
Supreme Court Justices Grill TikTok’s Lawyer in National Security Case
Jan 12, 2025 by
CPI
FTC, DOJ Weigh Antitrust Issues in Musk’s OpenAI Case
Jan 12, 2025 by
CPI
UK Trial Begins as Apple Defends App Store Fees in £1.5 Billion Case
Jan 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand